TRAC and Power3 SPPL3 gene-knockout allogeneic CD19 CAR-T cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TRAC and Power3 SPPL3 gene-knockout allogeneic CD19 CAR-T cell therapy, covering 2025-05-25 to 2025-05-25. Get the full timeline:
Most recent: Clinical Trial Update: TRAC and Power3 (SPPL3) Genes Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-NHL [Phase 1, Phase 2]